Stoke Therapeutics, Inc.
STOK· Nasdaq
Released May 10, 2022, before the open
10-Q filed May 10, 2022, 40 days after period end · 0001564590-22-019268
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $3.00M | — | — | — |
| Net Income | -$24.65M | -$16.79M | -$11.04M | -$5.74M |
| EPS Diluted |
Stoke Therapeutics, Inc. · CIK 1623526 · Engraved from SEC EDGAR
| -$0.66 |
| -$0.46 |
| -$0.34 |
| -$6.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.